Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study
Arthur Roberts,1–3 Alec Sithole,4 Marcos Sedghi,5 Charles A Walker,6,7 Theresa M Quinn,8 1Indiana Craniofacial Center, 2Department of Oral Pathology, Medicine and Radiology, Indiana University School of Dentistry, Indianapolis, IN, USA; 3Department of Anesthesia, Critical Care, and Pain Ma...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-11-01
|
| Series: | Medical Devices: Evidence and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/minimal-adverse-effects-profile-following-implantation-of-periauricula-peer-reviewed-article-MDER |
| _version_ | 1818839466967564288 |
|---|---|
| author | Roberts A Sithole A Sedghi M Walker CA Quinn TM |
| author_facet | Roberts A Sithole A Sedghi M Walker CA Quinn TM |
| author_sort | Roberts A |
| collection | DOAJ |
| description | Arthur Roberts,1–3 Alec Sithole,4 Marcos Sedghi,5 Charles A Walker,6,7 Theresa M Quinn,8 1Indiana Craniofacial Center, 2Department of Oral Pathology, Medicine and Radiology, Indiana University School of Dentistry, Indianapolis, IN, USA; 3Department of Anesthesia, Critical Care, and Pain Management, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK; 4Department of Computer Science, Mathematics and Physics, Missouri Western State University, St Joseph, MO, 5Conservative Care Specialists Medical Group, Los Angeles, CA, 6Walker Pain Management Center, Jackson, TN, 7Bethel University, Paris, TN, 8Wisconsin Pain Solutions, Menomonee Falls, WI, USA Abstract: The periauricular percutaneous implantation of the Neuro-Stim System™ family of devices EAD, MFS, and BRIDGE is a procedure involving the use of a non-opiate, neuromodulation analgesic for relieving acute and chronic pain. It has been approved as a minimal-risk procedure by multiple governmental and institutional facilities. This retrospective report of findings will help quantify the incidence of clinically observed bleeding, localized dermatitis, and infections at the implantation sites of the electrode/needle arrays, dermatitis at the site of the generator, and patient syncope. A total of 1,207 devices, each producing up to 16 percutaneous punctures, for a total of 19,312 punctures were monitored for adverse effects, based on retrospective chart audits conducted at six clinical facilities over a 1-year period. Keywords: clinical risks and discomfort, percutaneous auricular neuro-stimulation, Neuro-Stim System™ devices, EAD, MFS, Bridge, neuromodulation, adverse effects |
| first_indexed | 2024-12-19T03:54:45Z |
| format | Article |
| id | doaj.art-3a767777e98a4c1a9c6046983d71db8f |
| institution | Directory Open Access Journal |
| issn | 1179-1470 |
| language | English |
| last_indexed | 2024-12-19T03:54:45Z |
| publishDate | 2016-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Medical Devices: Evidence and Research |
| spelling | doaj.art-3a767777e98a4c1a9c6046983d71db8f2022-12-21T20:36:51ZengDove Medical PressMedical Devices: Evidence and Research1179-14702016-11-01Volume 938939329849Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort studyRoberts ASithole ASedghi MWalker CAQuinn TMArthur Roberts,1–3 Alec Sithole,4 Marcos Sedghi,5 Charles A Walker,6,7 Theresa M Quinn,8 1Indiana Craniofacial Center, 2Department of Oral Pathology, Medicine and Radiology, Indiana University School of Dentistry, Indianapolis, IN, USA; 3Department of Anesthesia, Critical Care, and Pain Management, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK; 4Department of Computer Science, Mathematics and Physics, Missouri Western State University, St Joseph, MO, 5Conservative Care Specialists Medical Group, Los Angeles, CA, 6Walker Pain Management Center, Jackson, TN, 7Bethel University, Paris, TN, 8Wisconsin Pain Solutions, Menomonee Falls, WI, USA Abstract: The periauricular percutaneous implantation of the Neuro-Stim System™ family of devices EAD, MFS, and BRIDGE is a procedure involving the use of a non-opiate, neuromodulation analgesic for relieving acute and chronic pain. It has been approved as a minimal-risk procedure by multiple governmental and institutional facilities. This retrospective report of findings will help quantify the incidence of clinically observed bleeding, localized dermatitis, and infections at the implantation sites of the electrode/needle arrays, dermatitis at the site of the generator, and patient syncope. A total of 1,207 devices, each producing up to 16 percutaneous punctures, for a total of 19,312 punctures were monitored for adverse effects, based on retrospective chart audits conducted at six clinical facilities over a 1-year period. Keywords: clinical risks and discomfort, percutaneous auricular neuro-stimulation, Neuro-Stim System™ devices, EAD, MFS, Bridge, neuromodulation, adverse effectshttps://www.dovepress.com/minimal-adverse-effects-profile-following-implantation-of-periauricula-peer-reviewed-article-MDERThe peri-auricular percutaneous implantation of the Neuro-Stim System (NSS©) family of devices EAD©MFS©BRIDGE© (Innovative Health SolutionsVersailles IN) is a non-opiateneuromodulation analgesic used for acute and chronic pain conditions. It is cleared as a minimal risk procedure by multiple governmental and institutional facilities. This retrospective report of findings will help quantify the incidence of clinically observed bleedinglocalized dermatitis and infections at the implantation sites of the electrode/needle arraysdermatitis at the site of the generatorand patient syncope. A total of 1207 deviceseach producing up to 16 percutaneous puncturesfor a total of 19312 punctures were monitored for adverse effectsbased on retrospective chart audits conducted at 6 clinical facilities over a one-year period. |
| spellingShingle | Roberts A Sithole A Sedghi M Walker CA Quinn TM Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study Medical Devices: Evidence and Research The peri-auricular percutaneous implantation of the Neuro-Stim System (NSS©) family of devices EAD© MFS© BRIDGE© (Innovative Health Solutions Versailles IN) is a non-opiate neuromodulation analgesic used for acute and chronic pain conditions. It is cleared as a minimal risk procedure by multiple governmental and institutional facilities. This retrospective report of findings will help quantify the incidence of clinically observed bleeding localized dermatitis and infections at the implantation sites of the electrode/needle arrays dermatitis at the site of the generator and patient syncope. A total of 1 207 devices each producing up to 16 percutaneous punctures for a total of 19 312 punctures were monitored for adverse effects based on retrospective chart audits conducted at 6 clinical facilities over a one-year period. |
| title | Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study |
| title_full | Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study |
| title_fullStr | Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study |
| title_full_unstemmed | Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study |
| title_short | Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study |
| title_sort | minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators a retrospective cohort study |
| topic | The peri-auricular percutaneous implantation of the Neuro-Stim System (NSS©) family of devices EAD© MFS© BRIDGE© (Innovative Health Solutions Versailles IN) is a non-opiate neuromodulation analgesic used for acute and chronic pain conditions. It is cleared as a minimal risk procedure by multiple governmental and institutional facilities. This retrospective report of findings will help quantify the incidence of clinically observed bleeding localized dermatitis and infections at the implantation sites of the electrode/needle arrays dermatitis at the site of the generator and patient syncope. A total of 1 207 devices each producing up to 16 percutaneous punctures for a total of 19 312 punctures were monitored for adverse effects based on retrospective chart audits conducted at 6 clinical facilities over a one-year period. |
| url | https://www.dovepress.com/minimal-adverse-effects-profile-following-implantation-of-periauricula-peer-reviewed-article-MDER |
| work_keys_str_mv | AT robertsa minimaladverseeffectsprofilefollowingimplantationofperiauricularpercutaneouselectricalnervefieldstimulatorsaretrospectivecohortstudy AT sitholea minimaladverseeffectsprofilefollowingimplantationofperiauricularpercutaneouselectricalnervefieldstimulatorsaretrospectivecohortstudy AT sedghim minimaladverseeffectsprofilefollowingimplantationofperiauricularpercutaneouselectricalnervefieldstimulatorsaretrospectivecohortstudy AT walkerca minimaladverseeffectsprofilefollowingimplantationofperiauricularpercutaneouselectricalnervefieldstimulatorsaretrospectivecohortstudy AT quinntm minimaladverseeffectsprofilefollowingimplantationofperiauricularpercutaneouselectricalnervefieldstimulatorsaretrospectivecohortstudy |